These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 12235450
1. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events. van Riemsdijk MM, Sturkenboom MC, Ditters JM, Ligthelm RJ, Overbosch D, Stricker BH. Clin Pharmacol Ther; 2002 Sep; 72(3):294-301. PubMed ID: 12235450 [Abstract] [Full Text] [Related]
2. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574 [Abstract] [Full Text] [Related]
3. Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study. Schlagenhauf P, Johnson R, Schwartz E, Nothdurft HD, Steffen R. J Travel Med; 2009 Oct 01; 16(1):42-5. PubMed ID: 19192127 [Abstract] [Full Text] [Related]
14. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision. Senn N, D'Acremont V, Landry P, Genton B. Am J Trop Med Hyg; 2007 Dec 01; 77(6):1010-4. PubMed ID: 18165513 [Abstract] [Full Text] [Related]
15. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Patel SN, Kain KC. Expert Rev Anti Infect Ther; 2005 Dec 01; 3(6):849-61. PubMed ID: 16307498 [Abstract] [Full Text] [Related]
16. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. van Riemsdijk MM, Sturkenboom MC, Ditters JM, Tulen JH, Ligthelm RJ, Overbosch D, Stricker BH. Br J Clin Pharmacol; 2004 Apr 01; 57(4):506-12. PubMed ID: 15025750 [Abstract] [Full Text] [Related]
17. Atovaquone-proguanil for prophylaxis and treatment of malaria. Marra F, Salzman JR, Ensom MH. Ann Pharmacother; 2003 Sep 01; 37(9):1266-75. PubMed ID: 12921511 [Abstract] [Full Text] [Related]
18. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate. Gupta RK, Van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F. Am J Trop Med Hyg; 2005 Aug 01; 73(2):267-8. PubMed ID: 16103586 [Abstract] [Full Text] [Related]
19. [What is the value of the combination atovaquone-proguanil for the clinician?]. Delmont J. Med Trop (Mars); 2002 Aug 01; 62(3):232-6. PubMed ID: 12244917 [Abstract] [Full Text] [Related]